This week, the Burlingame-based bioelectronic medicine company announced it received $77m in new funding, led by Ascension Ventures and new investors Dolby Family Ventures, Peak6 Strategic Capital, a division of PEAK6 Investments, and Innovatus Capital Partners. The company said it will use the new financing to expand patient access, accelerate innovation and explore indications including in Parkinson’s disease as well as psychiatry, cardiology and autoimmune disease.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?